21068147

Source:http://linkedlifedata.com/resource/pubmed/id/21068147

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0087111, umls-concept:C0178874, umls-concept:C0205210, umls-concept:C0913469, umls-concept:C1519424, umls-concept:C1521991, umls-concept:C2603343
pubmed:issue	2
pubmed:dateCreated	2011-2-7
pubmed:abstractText	There is concern that pegvisomant could be associated with a higher risk of tumor growth. The rate and possible determinants of this tumor growth are unknown.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0375362
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Human Growth Hormone, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Somatotropin, http://linkedlifedata.com/resource/pubmed/chemical/pegvisomant
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	1945-7197
pubmed:author	pubmed-author:Alvarez-EscoláCC, pubmed-author:BernabeuII, pubmed-author:Cameselle-TeijeiroJJ, pubmed-author:CastañoJ PJP, pubmed-author:Fernandez-RodriguezEE, pubmed-author:GaheteM DMD, pubmed-author:LucasTT, pubmed-author:Luque-RamirezMM, pubmed-author:LuqueR MRM, pubmed-author:ManzanaresRR, pubmed-author:MarazuelaMM, pubmed-author:PaniaguaA EAE
pubmed:issnType	Electronic
pubmed:volume	96
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	E251-9
pubmed:meshHeading	pubmed-meshheading:21068147-Acromegaly, pubmed-meshheading:21068147-Adenoma, pubmed-meshheading:21068147-Adolescent, pubmed-meshheading:21068147-Adult, pubmed-meshheading:21068147-Aged, pubmed-meshheading:21068147-Aged, 80 and over, pubmed-meshheading:21068147-Combined Modality Therapy, pubmed-meshheading:21068147-Cross-Sectional Studies, pubmed-meshheading:21068147-Disease Progression, pubmed-meshheading:21068147-Female, pubmed-meshheading:21068147-Growth Hormone-Secreting Pituitary Adenoma, pubmed-meshheading:21068147-Human Growth Hormone, pubmed-meshheading:21068147-Humans, pubmed-meshheading:21068147-Immunohistochemistry, pubmed-meshheading:21068147-Magnetic Resonance Imaging, pubmed-meshheading:21068147-Male, pubmed-meshheading:21068147-Middle Aged, pubmed-meshheading:21068147-Paraffin Embedding, pubmed-meshheading:21068147-Pituitary Gland, pubmed-meshheading:21068147-Receptors, Somatotropin, pubmed-meshheading:21068147-Regression Analysis, pubmed-meshheading:21068147-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:21068147-Risk Factors, pubmed-meshheading:21068147-Young Adult
pubmed:year	2011
pubmed:articleTitle	Somatotroph tumor progression during pegvisomant therapy: a clinical and molecular study.
pubmed:affiliation	Endocrinology Division, Hospital Universitario de la Princesa, Diego de Leon 62, 28006, Madrid, Spain. mmarazuela.hlpr@salud.madrid.org
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't, Multicenter Study